BCRX - What's Going On With BioCryst Pharmaceuticals Stock? | Benzinga
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) shares are trading higher Monday. The company provided preliminary, unaudited net revenue figures for Orladeyo (berotralstat) last Friday.
What To Know:
BioCryst announced its preliminary, unaudited Orladeyo net revenue of $89.9 million for the fourth quarter and full year 2023 net revenue of $325 million last Friday.
The company also said that it expects full year 2024 global ...